Efficacy comparison of oxcarbazepine and levetiracetam monotherapy among patients with newly diagnosed focal epilepsy in China: A multicenter, open‐label, randomized study

AIMS: This multicenter, open‐label, randomized study (Registration No. ChiCTR‐OCH‐14004528) aimed to compare the efficacy and effects of oxcarbazepine (OXC) with levetiracetam (LEV) as monotherapies on patient quality of life and mental health for patients with newly diagnosed focal epilepsy from Ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Haoyue, Deng, Xuejun, Feng, Li, Lian, Yajun, Han, Xiong, Guo, Zhenli, Gou, Yulan, Du, Yuanmin, Xie, Longshan, Yao, Dongai, Liu, Yonghong, Wu, Qiang, Lan, Song, Liu, Kaisheng, Zhan, Peiyan, Wang, Xiahong, Dang, Jingxia, Hou, Yunqi, Chen, Keqiang, Zhu, Yulan, Shi, Yuliang, Yu, Yunli, Xiao, Bo, Zhu, Suiqiang, Meng, Hongmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160445/
https://www.ncbi.nlm.nih.gov/pubmed/35429132
http://dx.doi.org/10.1111/cns.13840

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160445/
https://www.ncbi.nlm.nih.gov/pubmed/35429132
http://dx.doi.org/10.1111/cns.13840

Ejemplares similares